Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

111
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
111
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

213
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
213
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

201
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
201
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

74
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
74
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

109
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
109
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

640
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
640

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SPSGL: uncovering psychiatric network mechanisms via structural-prior guided synaptic graph learning.

Health information science and systems·2026
Same author

Predicting piRNA-Disease Associations Based on Dual-View Learning and Multi-head Self-Attention Mechanism Fusion.

Interdisciplinary sciences, computational life sciences·2026
Same author

Integration of Transcriptomics With Interpretable Artificial Intelligence for Identifying Molecular Signatures of Physiological Stress in Sleep Deprivation.

Journal of cellular and molecular medicine·2026
Same author

MicroRNAs in endometriosis: bioinformatics resources, machine learning strategies, and multi-omics perspectives.

Journal of translational medicine·2026
Same author

Noninvasive Risk Stratification Based on Renal Tubular Injury Phenotypes: A Deep Learning Study for Predicting Vesicoureteral Reflux in Children.

Journal of cellular and molecular medicine·2026
Same author

Cross-algorithm machine learning and consensus features for early disseminated intravascular coagulation risk prediction in sepsis-induced coagulopathy.

Journal of translational medicine·2026

Related Experiment Video

Updated: Aug 14, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K

Modeling and analyzing single-cell multimodal data with deep parametric inference.

Huan Hu1,2,3, Zhen Feng4, Hai Lin3

  • 1Department of Physics, and Fujian Provincial Key Laboratory for Soft Functional Materials Research, Xiamen University, Xiamen 361005, China.

Briefings in Bioinformatics
|January 15, 2023
PubMed
Summary

Deep Parametric Inference (DPI) is a new framework for analyzing single-cell multimodal data. It offers a comprehensive approach to understanding cellular heterogeneity and disease mechanisms, outperforming existing methods.

Keywords:
COVID-19data integrationdeep learningmulti-omicssingle-cell

More Related Videos

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.2K
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

4.9K

Related Experiment Videos

Last Updated: Aug 14, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.2K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.2K
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

4.9K

Area of Science:

  • Computational Biology
  • Genomics
  • Bioinformatics

Background:

  • Single-cell multimodal sequencing technologies offer multi-view insights into cellular heterogeneity and disease mechanisms.
  • Existing analysis methods may not fully capture the complexity of multimodal single-cell data.

Purpose of the Study:

  • To introduce Deep Parametric Inference (DPI), a comprehensive end-to-end framework for single-cell multimodal data analysis.
  • To demonstrate DPI's capability in characterizing cellular heterogeneity and analyzing disease progression.

Main Methods:

  • DPI transforms single-cell multimodal data into a multimodal parameter space by inferring individual modal parameters.
  • The framework was evaluated on cord blood mononuclear cells (CBMC) and peripheral blood mononuclear cells (PBMC) datasets.
  • Comparative analyses were performed against state-of-the-art methods.

Main Results:

  • DPI's multimodal parameter space provides a more comprehensive characterization of cellular heterogeneity than individual modalities.
  • DPI demonstrates superior performance compared to existing methods across multiple datasets.
  • DPI effectively analyzes disease progression, such as in COVID-19, and can reference cell types without batch effects.
  • A cell state vector field was proposed to analyze cell state transformation patterns.

Conclusions:

  • DPI is a powerful framework for single-cell multimodal analysis, offering novel biological insights.
  • The framework facilitates a deeper understanding of cellular heterogeneity and disease mechanisms.
  • DPI is publicly available with code, datasets, and manuals for biomedical researchers.